AI could help spot eye disease in kids with diabetes

NCT ID NCT07149142

Recruiting now Diagnosis Sponsor: University Hospital, Motol Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 21, 2026 · Updated 2 times

Summary

This study will test whether artificial intelligence (AI) can effectively screen for diabetic retinopathy (eye damage) in 400 children with type 1 diabetes. Each child will have their eyes examined using an AI-powered camera, standard eye exams, and a detailed scan. The researchers will compare the AI results to the standard methods to see if AI is a reliable, easy-to-use screening tool. They will also look at how common eye problems are in this group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Artificial intelligence software for diabetic retinopathy screening
What this could lead to: If successful, this could make eye screening faster and easier for children with diabetes, potentially catching problems earlier.
What could go wrong: This is a small, early feasibility study at one center. The AI may not be as accurate as standard exams, and results may not apply to all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic neuropathy diabetic retinopathy type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES MELLITUS

Contacts and locations

Locations

University Hospital Motol
RECRUITING

Prague, Prague 5, 15006, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.